RecruitingNCT07299097

Epidemiology of Narcolepsy Type 1 and Type 2 in Spain


Sponsor

Takeda

Enrollment

100 participants

Start Date

Dec 2, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The main purpose of this study is to find out how many people in Spain have been diagnosed with narcolepsy type 1 and type 2, and how many new participants are diagnosed each year. Narcolepsy is a rare sleep disorder that causes excessive daytime sleepiness. The researchers will look at medical records from hospitals across Spain to count participants with these conditions and understand patterns in diagnosis over time.


Eligibility

Min Age: 0 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying No intervention for people with narcolepsy type 1 and narcolepsy type 2. The study is currently recruiting participants at 10 locations. People eligible for this study include aged 0 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention

As this is an observational study, no intervention will be administered.


Locations(10)

Hospital General de Castellón

Castellon, Castellon, Spain

Hospital de Navarra

Pamplona, Navarre, Spain

Hospital de la Ribera

Alzira, Valencia, Spain

Hospital Vall d'Hebrón

Barcelona, Spain

Hospital Clinic de Barcelona

Barcelona, Spain

Hospital Virgen de las Nieves

Granada, Spain

Hospital Clínico San Carlos

Madrid, Spain

Hospital La Paz

Madrid, Spain

Hospital Virgen Macarena

Seville, Spain

Hospital de Araba

Vitoria-Gasteiz, Álava, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07299097


Related Trials